Anthracyclines: doxorubicine, daunorubicine, idarubicin, epirubicin, mitoxantrone
|
|
|
Platinum : cisplatin, carboplantin, oxaliplatin
|
|
|
Antimetabolites: Fluorouracil, Capecitabine
|
|
|
Alkylating agents : Cyclophosphamide
|
|
|
Antimicrotubule agent : Paclitaxel
|
|
|
HER2 inhibitors: Trastuzumab, Pertuzumab, trastuzumab emtansine, lapatinib
|
|
|
VEGF signaling pathway inhibitors: Bevacizumab, Aflibercept, Ramucirumab, Sunitinib, sorafenib, pazopanib, axitinib, vandetanib, regorafenib, cabozantinib, lenvatinib
|
|
|
Multitargeted tyrosine kinase inhibitors: dasatinib, nilotinib, Ponatinib
|
|
|
Other multitargeted tyrosine kinase inhibitors: crizotinib, ceritinib, everolimus, temsirolimus, ibrutinib, trametinib
|
|
|
Immunomodulatory drug: thalidomide, lenalidomide, pomalidomide
|
|
|
Proteasome inhibitors: bortezomib, carfilzomib
|
|
|
Immune checkpoint inhibitors: Pembrolizumab, nivolumab, Ipilimumab
|
|
|